Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LOC100126583///IGHV3OR16-13///IGHA2///IGHA1///IGH@ |
| Upstream (Parents) |
|---|
| (<<) IGJ → LOC100126583///IGHV3OR16-13///IGHA2///IGHA1///IGH@ |
| (<<) IGK@///IGKC → LOC100126583///IGHV3OR16-13///IGHA2///IGHA1///IGH@ |
| (<<) TRAC///TRAJ17///TRAV20///TRA@ → LOC100126583///IGHV3OR16-13///IGHA2///IGHA1///IGH@ |
| Downstream (Children) |
|---|
| LOC100126583///IGHV3OR16-13///IGHA2///IGHA1///IGH@ → C6orf54 (>>) |
| LOC100126583///IGHV3OR16-13///IGHA2///IGHA1///IGH@ → SLC22A6 (>>) |
| LOC100126583///IGHV3OR16-13///IGHA2///IGHA1///IGH@ → CHRNA10 (>>) |
| LOC100126583///IGHV3OR16-13///IGHA2///IGHA1///IGH@ → SRP72 (>>) |
| LOC100126583///IGHV3OR16-13///IGHA2///IGHA1///IGH@ → MTHFR (>>) |
| LOC100126583///IGHV3OR16-13///IGHA2///IGHA1///IGH@ → P2RX5 (>>) |
| LOC100126583///IGHV3OR16-13///IGHA2///IGHA1///IGH@ → APAF1 (>>) |
| LOC100126583///IGHV3OR16-13///IGHA2///IGHA1///IGH@ → LOC652494///IGHV4-31///IGHM///IGHG3///IGHG2///IGHG1///IGHD///IGHA1 (>>) |
| LOC100126583///IGHV3OR16-13///IGHA2///IGHA1///IGH@ → LOC731884 (>>) |
